Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use

Posts

May 2, 2018

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe. Read More… U.S. Patented Application 1

CONTINUE READING
January 9, 2018

Asepsis Announces the Grant of Canada Patent Application CA2937327

CONTINUE READING
November 15, 2017

Asepsis Medical Announces the Notice of Patent Grant US 9775950

Asepsis Medical Announces the Notice of Patent Grant US 9775950 for the Vi-Syringe™ – Vision Impaired Syringe.

CONTINUE READING
October 31, 2017

Asepsis Medical Technologies is awarded Best of Sarasota 2017 for Medical Device Development.

CONTINUE READING
October 6, 2017

Asepsis Medical Announces Notice of Patent Grant 2015209535

Asepsis Medical Announces Notice of Patent Grant 2015209535 in Australia for the Momenta-Dose™ – Force Actuated Injection.

CONTINUE READING
September 29, 2017

Asepsis Medical announces the Notice of Allowance in Mexico for Patent No. 14/09038

Asepsis Medical announces the Notice of Allowance in Mexico for Patent No. 14/09038 encompassing the Dose-2-Weight Syringe® and Safe-T-Syringe® as well as related Calibrated Drug Delivery™ injection k

CONTINUE READING
September 19, 2017

Asepsis Medical announces the Notice of Allowance in Japan.

Asepsis Medical receives Notice of Allowance in Japan for Patent 2014-554822 encompassing the Oral and Parenteral Dose-2-Weight Syringe® and related Calibrated Drug Deliv

CONTINUE READING
September 15, 2017

Asepsis Medical announces the issuance of a third U.S. Patent, US 9750883

Asepsis Medical Technologies announces the issue of United States Patent 9750883 for its Oral-Dose-2-Weight Syringe® and Parenteral-Dose-2-Weight Syringe®. The Asepsis’&n

CONTINUE READING
May 26, 2017

Asepsis Medical Technologies announces the Certificate of Grant for Australian Patent Application 2013222819

Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Dose-2-Weight Syringe® and Safe-T-Dose® combinatorial drug injection kit. The Asepsis

CONTINUE READING
September 6, 2016

Asepsis Medical Technologies announces the USPTO issuance of Patent Number 9,433,726

Asepsis Medical Technologies announces the USPTO issuance of Patent Number U.S. Patent 9,433,726 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container th

CONTINUE READING
1 2 3 4

Copyright © 2022 Asepsis Medical Technologies, LLC. All rights reserved.